Skip to main content

Andrew Gottesdiener

Equibles does not estimate personal net worth.

Get an email with a short summary when Korsana Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get KRSA alerts

About Andrew Gottesdiener

Andrew Gottesdiener is recorded as Board Member at Korsana Biosciences, Inc. (KRSA) since September 8, 2026. Korsana Biosciences, Inc. reported in an 8-K filed September 11, 2026 that Andrew Gottesdiener was appointed member of the Audit Committee, effective September 8, 2026. Korsana Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korsana Biosciences, Inc. includes Jonathan Violin, Ph.D. (CEO and Board Member), Regina M. Graul (CEO and Board Member), Tomas Kiselak (Chairman and Board Member) and 7 others.

“On September 8, 2026, Heidi Henson, Andrew Gottesdiener, M.D. and Nimish Shah were appointed to the Audit Committee, and Heidi Henson, an "audit committee financial expert" within the meaning of the SEC regulations, was appointed the chair of the Audit Committee.”
Korsana Biosciences, Inc. Form 8-K, filed September 11, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Korsana Biosciences, Inc.

Recent activity